Transmitted drug resistances (TDRs) and HIV-1 diversity could affect treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and estimate the prevalence of resistance among drug naïve patients attending Sapienza University Hospital in Rome from 2006-2017.
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE / Mazzuti, Laura; Melengu, Taulant; Falasca, Francesca; Calabretto, Marianna; Cella, Eleonora; Ciccozzi, Massimo; Mezzaroma, Ivano; Iaiani, Giancarlo; Spaziante, Martina; D'Ettorre, Gabriella; Fimiani, Caterina; Vullo, Vincenzo; Antonelli, Guido; Turriziani, Ombretta. - In: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. - ISSN 2213-7165. - 20:(2020), pp. 298-303. [10.1016/j.jgar.2019.08.024]
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE
Mazzuti, Laura;Melengu, Taulant;Falasca, Francesca;Calabretto, Marianna;Mezzaroma, Ivano;Spaziante, Martina;d'Ettorre, Gabriella;Vullo, Vincenzo;Antonelli, Guido;Turriziani, Ombretta
2020
Abstract
Transmitted drug resistances (TDRs) and HIV-1 diversity could affect treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and estimate the prevalence of resistance among drug naïve patients attending Sapienza University Hospital in Rome from 2006-2017.| File | Dimensione | Formato | |
|---|---|---|---|
|
Mazzuti_Transmitted-drug_2020.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
709.97 kB
Formato
Adobe PDF
|
709.97 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
